(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDIDRIP

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDIDRIP

ST13

US500000087597387

Class

5, 44

Filing

87597387

Registration

5552268

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

04/10/2025

Trademark type

Word

Nice classes

5, 44

Filing date

09/06/2017

Registration date

08/28/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/08/2025

Last transaction

04/10/2025

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/24/2018

First use in commerce

06/24/2018

Drawing code

4

Owner type

01

Owner location

Pittsburgh, PA

Examiner

HWANG, JOHN

Current location

Historical data usage

Holders and representatives

Holders

Dicesaro, Anthony

Representatives

Jason R. Lee The Trademark Firm PLLC

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vitamin preparations for human consumption

Class 44

administering intravenous infusion of vitamin and nutrient solutions for health purposes

Publications

History of USPTO decisions and trademark events.

31 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

04/08/2025

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

04/08/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/07/2025

ES8R

TEAS SECTION 8 RECEIVED

09/13/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/28/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

08/28/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/21/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/20/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/20/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/19/2018

IUAF

USE AMENDMENT FILED

06/26/2018

EISU

TEAS STATEMENT OF USE RECEIVED

06/26/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/17/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/20/2018

PUBO

PUBLISHED FOR OPPOSITION

02/20/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/31/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/17/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

01/15/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/15/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

01/15/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/15/2018

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

01/15/2018

PBSR

WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST

01/15/2018

ALIE

ASSIGNED TO LIE

01/01/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/13/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

12/13/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/13/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

12/13/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/13/2017

DOCK

ASSIGNED TO EXAMINER

12/11/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/12/2017

Continuous trademark protection

Get notified about every new filing that threatens MEDIDRIP or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.